Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Seven Core Pieces of the Puzzle: What to Consider When Selecting an Analytical Lab
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Updates on the Value of a Day of Delay in Drug Development
CEO Spotlight: Matthew Stober
CDMO Specialization
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Cytiva, Pear Bio Partner on Personalized Cancer Medicine
Evonik Launches EUDRACAP for the Targeted Delivery of Oral Drugs
SK pharmteco, Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Multiply Labs, Legend Biotech Partner on Automated Cell Therapy Manufacturing
ten23 health Opens New VIVA2 Facility in Switzerland
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
FUJIFILM Irvine Scientific Adds Key Products to Life Sciences Portfolio
Thermo Fisher Expands OSD Development and Manufacturing Capabilities
Acumen, Vetter Expand Alliance for Manufacture of Alzheimer’s Drug
ten23 health Opens New VIVA2 Facility in Switzerland
Ascend Advanced Therapies Expands Global Infrastructure
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
SK pharmteco, Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Pharma Matters Q&A: Rising Above the Rest
Avara Highlights Recent Expansions and Core Capabilities
CEO Spotlight: Prasad Raje
Optimizing Softgel Formulations
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
FUJIFILM Irvine Scientific Adds Key Products to Life Sciences Portfolio
Thermo Fisher Expands OSD Development and Manufacturing Capabilities
Cytiva, Pear Bio Partner on Personalized Cancer Medicine
Evonik Launches EUDRACAP for the Targeted Delivery of Oral Drugs
SK pharmteco, Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
FDA sIRB Mandate: A Chance to Reassess Site Performance
Rottendorf Pharma Selects ValGenesis’ VLMS
U.S. House of Representatives Passes the BIOSECURE Act
Post-COVID Trends in Biopharma Contract Manufacturing
Pharma Matters Q&A: Alfasigma
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
Syngene International Ltd.
INCOG BioPharma Services
Lannett CDMO
UBI Pharma Inc.
August Bioservices
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
Syngene International Ltd.
INCOG BioPharma Services
Lannett CDMO
UBI Pharma Inc.
August Bioservices
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
YOU SEARCHED BY...
Gilead Sciences, Inc.
Remove all
SEARCH BY...
Contract Service Directory
Contract Services Directory
(1070)
Country
Argentina
(1)
Australia
(9)
Austria
(1)
Belgium
(3)
Canada
(59)
China
(26)
Denmark
(2)
Estonia
(2)
Finland
(1)
France
(14)
Germany
(43)
Greece
(2)
Hong Kong
(1)
Hungary
(3)
India
(79)
Indonesia
(1)
Ireland
(1)
Israel
(3)
Italia
(6)
Japan
(2)
Latvia
(1)
Lithuania
(1)
Mexico
(2)
New Zealand
(2)
Peru
(1)
Poland
(2)
Portugal
(3)
Romania
(1)
Singapore
(1)
Slovenia
(2)
South Korea
(6)
Spain
(16)
Sweden
(3)
Switzerland
(22)
Taiwan
(4)
The Czech Republic
(2)
The Netherlands
(5)
Turkey
(2)
Ukraine
(2)
United Kingdom
(55)
United States
(700)
Vietnam
(1)
Contract Service Directory
Company Overview
Content Not Found
Gilead Sciences, Inc.
Company Headquarters
650 Cliffside Drive
San Dimas, CA 91773
United States
View Phone No.
Request More Info
Contract Service Directory
Contract Manufacturing
Drug Delivery Systems
Lyophilization
Parenterals Development
Syringe Filling
Related Content
Breaking News
|
Drug Development
|
Industry News
Veklury Reduced Risk of Hospitalization in High-Risk COVID-19 Patients
Veklury demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19 related hospitalization.
09.22.21
Breaking News
|
Clinical Trials
|
Drug Development
|
Trials & Filings
Gilead, Novo Nordisk Expand NASH Alliance
Phase II trial to investigate Novo’s semaglutide and a combination of Gilead’s cilofexor and firsocostat, alone and in combination in cirrhosis due to NASH.
Kristin Brooks
03.18.21
Breaking News
|
Collaborations & Alliances
|
Industry News
|
Parenterals
|
Solid Dosage/Creams/Ointments
Gilead and Merck Ink HIV Agreement
Collaboration to focus on oral and injectable formulations of lenacapavir and islatravir.
Tim Wright, Editor, Contract Pharma
03.15.21
Breaking News
|
Drug Development
|
Industry News
Gilead, Gritstone Enter Vax Platform Pact for HIV Cure
Aims to develop HIV-specific vaccine using Gritstone’s prime-boost vaccine platform with antigens developed by Gilead.
Kristin Brooks
02.01.21
Breaking News
|
Industry News
Gilead to Acquire MYR GmbH for €1.15B
Gains Hepcludex, a first-in-class treatment for HDV; anticipates accelerated global launch as a result of the acquisition.
Contract Pharma Staff
12.10.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
Gilead Bolsters Biologics Capabilities
Licenses ProteoNic’s 2G UNic Technology Platform for production of biologics.
Contract Pharma Staff
11.10.20
Breaking News
|
Financial Reports
Financial Report: Gilead
Veklury (remdesivir) revenues were $873 million in the third quarter.
Contract Pharma Staff
10.28.20
Breaking News
|
Drug Development
|
Trials & Filings
Gilead’s Remdesivir Wins FDA Approval to Treat COVID-19
Veklury is now the first and only approved COVID-19 treatment in the U.S.
Contract Pharma Staff
10.23.20
Promotions & Moves
CROS NT Appoints President of North American Ops
Paul has more than 25 years of experience serving customers and managing clinical trials
05.30.17
APIs
|
cGMP Manufacture
|
Industry News
Cambrex Expands Capacity and Capabilites in Sweden
Installs new multi-purpose reactors, adds continuous flow technology at Karlskoga Facility
05.30.17
Collaborations & Alliances
|
Drug Development
Array, BMS in Opdivo Clinical Combo Alliance
To investigate Array's binimetinib in combination with BMS' Opdivo and Opdivo + Yervoy regimen in colorectal cancer
05.30.17
Collaborations & Alliances
|
Drug Development
Janssen Biotech, Protagonist in Exclusive PTG-200 Pact
To develop, manufacture and commercialize PTG-200 for Crohn's disease and ulcerative colitis
05.30.17
cGMP Manufacture
|
Clinical Trial Materials
|
Formulation Development
|
Industry News
Quotient Clinical Appoints Chief Commercial Officer
Kalim to support further expansion of global commercial footprint
05.30.17
Drug Development
|
Industry News
Amygdala Acquires Gilead's Addiction Disorder Candidiate
Phase II ready asset has potential to become a treatment for addiction
02.17.17
Promotions & Moves
Gilead Appoints Commercial Ops EVP
Meyers responsible for operations in North America, Europe and Japan
11.18.16
7 Gilead Sciences
...
07.11.16
Drug Development
|
Drug Discovery
|
Industry News
Ligand, Gilead in OmniAb Platform Pact
Gilead will use the OmniRat, OmniMouse and OmniFlic platforms to discover mono- and bispecific antibodies
07.11.16
APIs
|
Breaking News
|
cGMP Manufacture
|
Facilities
|
Industry News
|
Scale-up/Technology Transfer
PharmaChem Breaks Ground on $130M Expansion Project
New facility is dedicated to the exclusive production of Gilead medicines.
04.06.16
Promotions & Moves
Gilead CEO Steps Down
Milligan to succeed Martin
02.01.16